Skip to main content
  • FDA approves antidote to rivaroxaban, apixaban

    FDA approves antidote to rivaroxaban, apixaban

  • FDA approves antidote to rivaroxaban, apixaban

    The U.S. Food and Drug Administration has approved andexanet alfa (Andexxa), according to the drug’s manufacturer, Portola Pharmaceuticals Inc.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details